カテゴリー： QYResearch, 世界

世界の呼吸器合胞体ウイルス（RSV）治療薬市場 2019年

【英語タイトル】Global Respiratory Syncytial Virus (RSV) Therapeutics Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X14332）・商品コード：DATA909X14332
・発行会社（調査会社）：QYResearch
・発行日：2019年11月20日（※2024年版があります。お問い合わせください）
・ページ数：104
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、呼吸器合胞体ウイルス（RSV）治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、パリビズマブ、リバビリン、その他に、用途別には、病院薬局、ドラッグストア、小売薬局、その他にセグメント区分し、呼吸器合胞体ウイルス（RSV）治療薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・呼吸器合胞体ウイルス（RSV）治療薬の世界市場概要
・呼吸器合胞体ウイルス（RSV）治療薬の製造コスト構成分析
・呼吸器合胞体ウイルス（RSV）治療薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・呼吸器合胞体ウイルス（RSV）治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・呼吸器合胞体ウイルス（RSV）治療薬のセグメント分析（種類別）
（パリビズマブ、リバビリン、その他）
・呼吸器合胞体ウイルス（RSV）治療薬のセグメント分析（用途別）
（病院薬局、ドラッグストア、小売薬局、その他）
・呼吸器合胞体ウイルス（RSV）治療薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Roche、AstraZeneca、Merck、AbbVie、Valeant Pharmaceuticals、GlaxoSmithKline、ReViral、Gilead Sciences、Teva Pharmaceutical、）
・呼吸器合胞体ウイルス（RSV）治療薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Respiratory Syncytial Virus (RSV) Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Respiratory Syncytial Virus (RSV) Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Respiratory Syncytial Virus (RSV) Therapeutics market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Respiratory Syncytial Virus (RSV) Therapeutics in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Respiratory Syncytial Virus (RSV) Therapeutics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Roche
AstraZeneca
Merck
AbbVie
Valeant Pharmaceuticals
GlaxoSmithKline
ReViral
Gilead Sciences
Teva Pharmaceutical

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Palivizumab
Ribavirin
Others

Segment by Application
Hospital Pharmacies
Drug Stores
Retail Pharmacies
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Respiratory Syncytial Virus (RSV) Therapeutics
1.1 Definition of Respiratory Syncytial Virus (RSV) Therapeutics
1.2 Respiratory Syncytial Virus (RSV) Therapeutics Segment by Type
1.2.1 Global Respiratory Syncytial Virus (RSV) Therapeutics Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Palivizumab
1.2.3 Ribavirin
1.2.4 Others
1.3 Respiratory Syncytial Virus (RSV) Therapeutics Segment by Applications
1.3.1 Global Respiratory Syncytial Virus (RSV) Therapeutics Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.3.4 Retail Pharmacies
1.3.5 Others
1.4 Global Respiratory Syncytial Virus (RSV) Therapeutics Overall Market
1.4.1 Global Respiratory Syncytial Virus (RSV) Therapeutics Revenue (2014-2025)
1.4.2 Global Respiratory Syncytial Virus (RSV) Therapeutics Production (2014-2025)
1.4.3 North America Respiratory Syncytial Virus (RSV) Therapeutics Status and Prospect (2014-2025)
1.4.4 Europe Respiratory Syncytial Virus (RSV) Therapeutics Status and Prospect (2014-2025)
1.4.5 China Respiratory Syncytial Virus (RSV) Therapeutics Status and Prospect (2014-2025)
1.4.6 Japan Respiratory Syncytial Virus (RSV) Therapeutics Status and Prospect (2014-2025)
1.4.7 Southeast Asia Respiratory Syncytial Virus (RSV) Therapeutics Status and Prospect (2014-2025)
1.4.8 India Respiratory Syncytial Virus (RSV) Therapeutics Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Respiratory Syncytial Virus (RSV) Therapeutics
2.3 Manufacturing Process Analysis of Respiratory Syncytial Virus (RSV) Therapeutics
2.4 Industry Chain Structure of Respiratory Syncytial Virus (RSV) Therapeutics

3 Development and Manufacturing Plants Analysis of Respiratory Syncytial Virus (RSV) Therapeutics
3.1 Capacity and Commercial Production Date
3.2 Global Respiratory Syncytial Virus (RSV) Therapeutics Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Respiratory Syncytial Virus (RSV) Therapeutics
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Respiratory Syncytial Virus (RSV) Therapeutics Production and Capacity Analysis
4.2 Respiratory Syncytial Virus (RSV) Therapeutics Revenue Analysis
4.3 Respiratory Syncytial Virus (RSV) Therapeutics Price Analysis
4.4 Market Concentration Degree

5 Respiratory Syncytial Virus (RSV) Therapeutics Regional Market Analysis
5.1 Respiratory Syncytial Virus (RSV) Therapeutics Production by Regions
5.1.1 Global Respiratory Syncytial Virus (RSV) Therapeutics Production by Regions
5.1.2 Global Respiratory Syncytial Virus (RSV) Therapeutics Revenue by Regions
5.2 Respiratory Syncytial Virus (RSV) Therapeutics Consumption by Regions
5.3 North America Respiratory Syncytial Virus (RSV) Therapeutics Market Analysis
5.3.1 North America Respiratory Syncytial Virus (RSV) Therapeutics Production
5.3.2 North America Respiratory Syncytial Virus (RSV) Therapeutics Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Respiratory Syncytial Virus (RSV) Therapeutics Import and Export
5.4 Europe Respiratory Syncytial Virus (RSV) Therapeutics Market Analysis
5.4.1 Europe Respiratory Syncytial Virus (RSV) Therapeutics Production
5.4.2 Europe Respiratory Syncytial Virus (RSV) Therapeutics Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Respiratory Syncytial Virus (RSV) Therapeutics Import and Export
5.5 China Respiratory Syncytial Virus (RSV) Therapeutics Market Analysis
5.5.1 China Respiratory Syncytial Virus (RSV) Therapeutics Production
5.5.2 China Respiratory Syncytial Virus (RSV) Therapeutics Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Respiratory Syncytial Virus (RSV) Therapeutics Import and Export
5.6 Japan Respiratory Syncytial Virus (RSV) Therapeutics Market Analysis
5.6.1 Japan Respiratory Syncytial Virus (RSV) Therapeutics Production
5.6.2 Japan Respiratory Syncytial Virus (RSV) Therapeutics Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Respiratory Syncytial Virus (RSV) Therapeutics Import and Export
5.7 Southeast Asia Respiratory Syncytial Virus (RSV) Therapeutics Market Analysis
5.7.1 Southeast Asia Respiratory Syncytial Virus (RSV) Therapeutics Production
5.7.2 Southeast Asia Respiratory Syncytial Virus (RSV) Therapeutics Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Respiratory Syncytial Virus (RSV) Therapeutics Import and Export
5.8 India Respiratory Syncytial Virus (RSV) Therapeutics Market Analysis
5.8.1 India Respiratory Syncytial Virus (RSV) Therapeutics Production
5.8.2 India Respiratory Syncytial Virus (RSV) Therapeutics Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Respiratory Syncytial Virus (RSV) Therapeutics Import and Export

6 Respiratory Syncytial Virus (RSV) Therapeutics Segment Market Analysis (by Type)
6.1 Global Respiratory Syncytial Virus (RSV) Therapeutics Production by Type
6.2 Global Respiratory Syncytial Virus (RSV) Therapeutics Revenue by Type
6.3 Respiratory Syncytial Virus (RSV) Therapeutics Price by Type

7 Respiratory Syncytial Virus (RSV) Therapeutics Segment Market Analysis (by Application)
7.1 Global Respiratory Syncytial Virus (RSV) Therapeutics Consumption by Application
7.2 Global Respiratory Syncytial Virus (RSV) Therapeutics Consumption Market Share by Application (2014-2019)

8 Respiratory Syncytial Virus (RSV) Therapeutics Major Manufacturers Analysis
8.1 Roche
8.1.1 Roche Respiratory Syncytial Virus (RSV) Therapeutics Production Sites and Area Served
8.1.2 Roche Product Introduction, Application and Specification
8.1.3 Roche Respiratory Syncytial Virus (RSV) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 AstraZeneca
8.2.1 AstraZeneca Respiratory Syncytial Virus (RSV) Therapeutics Production Sites and Area Served
8.2.2 AstraZeneca Product Introduction, Application and Specification
8.2.3 AstraZeneca Respiratory Syncytial Virus (RSV) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Merck
8.3.1 Merck Respiratory Syncytial Virus (RSV) Therapeutics Production Sites and Area Served
8.3.2 Merck Product Introduction, Application and Specification
8.3.3 Merck Respiratory Syncytial Virus (RSV) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 AbbVie
8.4.1 AbbVie Respiratory Syncytial Virus (RSV) Therapeutics Production Sites and Area Served
8.4.2 AbbVie Product Introduction, Application and Specification
8.4.3 AbbVie Respiratory Syncytial Virus (RSV) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Valeant Pharmaceuticals
8.5.1 Valeant Pharmaceuticals Respiratory Syncytial Virus (RSV) Therapeutics Production Sites and Area Served
8.5.2 Valeant Pharmaceuticals Product Introduction, Application and Specification
8.5.3 Valeant Pharmaceuticals Respiratory Syncytial Virus (RSV) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 GlaxoSmithKline
8.6.1 GlaxoSmithKline Respiratory Syncytial Virus (RSV) Therapeutics Production Sites and Area Served
8.6.2 GlaxoSmithKline Product Introduction, Application and Specification
8.6.3 GlaxoSmithKline Respiratory Syncytial Virus (RSV) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 ReViral
8.7.1 ReViral Respiratory Syncytial Virus (RSV) Therapeutics Production Sites and Area Served
8.7.2 ReViral Product Introduction, Application and Specification
8.7.3 ReViral Respiratory Syncytial Virus (RSV) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Gilead Sciences
8.8.1 Gilead Sciences Respiratory Syncytial Virus (RSV) Therapeutics Production Sites and Area Served
8.8.2 Gilead Sciences Product Introduction, Application and Specification
8.8.3 Gilead Sciences Respiratory Syncytial Virus (RSV) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Teva Pharmaceutical
8.9.1 Teva Pharmaceutical Respiratory Syncytial Virus (RSV) Therapeutics Production Sites and Area Served
8.9.2 Teva Pharmaceutical Product Introduction, Application and Specification
8.9.3 Teva Pharmaceutical Respiratory Syncytial Virus (RSV) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served

9 Development Trend of Analysis of Respiratory Syncytial Virus (RSV) Therapeutics Market
9.1 Global Respiratory Syncytial Virus (RSV) Therapeutics Market Trend Analysis
9.1.1 Global Respiratory Syncytial Virus (RSV) Therapeutics Market Size (Volume and Value) Forecast 2019-2025
9.2 Respiratory Syncytial Virus (RSV) Therapeutics Regional Market Trend
9.2.1 North America Respiratory Syncytial Virus (RSV) Therapeutics Forecast 2019-2025
9.2.2 Europe Respiratory Syncytial Virus (RSV) Therapeutics Forecast 2019-2025
9.2.3 China Respiratory Syncytial Virus (RSV) Therapeutics Forecast 2019-2025
9.2.4 Japan Respiratory Syncytial Virus (RSV) Therapeutics Forecast 2019-2025
9.2.5 Southeast Asia Respiratory Syncytial Virus (RSV) Therapeutics Forecast 2019-2025
9.2.6 India Respiratory Syncytial Virus (RSV) Therapeutics Forecast 2019-2025
9.3 Respiratory Syncytial Virus (RSV) Therapeutics Market Trend (Product Type)
9.4 Respiratory Syncytial Virus (RSV) Therapeutics Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Respiratory Syncytial Virus (RSV) Therapeutics Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Respiratory Syncytial Virus (RSV) Therapeutics
Table Global Respiratory Syncytial Virus (RSV) Therapeutics Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Respiratory Syncytial Virus (RSV) Therapeutics Production Market Share by Types in 2018
Figure Palivizumab Product Picture
Figure Ribavirin Product Picture
Figure Others Product Picture
Table Global Respiratory Syncytial Virus (RSV) Therapeutics Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Respiratory Syncytial Virus (RSV) Therapeutics Consumption Market Share by Applications in 2018
Figure Hospital Pharmacies
Figure Drug Stores
Figure Retail Pharmacies
Figure Others
Figure Global Respiratory Syncytial Virus (RSV) Therapeutics Revenue (Million USD) (2014-2025)
Figure Global Respiratory Syncytial Virus (RSV) Therapeutics Production (K Units) (2014-2025)
Figure North America Respiratory Syncytial Virus (RSV) Therapeutics Market Size (Million USD) (2014-2025)
Figure Europe Respiratory Syncytial Virus (RSV) Therapeutics Market Size (Million USD) (2014-2025)
Figure China Respiratory Syncytial Virus (RSV) Therapeutics Market Size (Million USD) (2014-2025)
Figure Japan Respiratory Syncytial Virus (RSV) Therapeutics Market Size (Million USD) (2014-2025)
Figure Southeast Asia Respiratory Syncytial Virus (RSV) Therapeutics Market Size (Million USD) (2014-2025)
Figure India Respiratory Syncytial Virus (RSV) Therapeutics Market Size (Million USD) (2014-2025)
Table Respiratory Syncytial Virus (RSV) Therapeutics Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Respiratory Syncytial Virus (RSV) Therapeutics in 2018
Figure Manufacturing Process Analysis of Respiratory Syncytial Virus (RSV) Therapeutics
Figure Industry Chain Structure of Respiratory Syncytial Virus (RSV) Therapeutics
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Respiratory Syncytial Virus (RSV) Therapeutics Manufacturing Plants Distribution
Table Respiratory Syncytial Virus (RSV) Therapeutics Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Respiratory Syncytial Virus (RSV) Therapeutics Capacity (K Units) of Major Manufacturers (2014-2019)
Table Respiratory Syncytial Virus (RSV) Therapeutics Production (K Units) of Major Manufacturers (2014-2019)
Table Respiratory Syncytial Virus (RSV) Therapeutics Production Market Share of Major Manufacturers (2014-2019)
Figure Respiratory Syncytial Virus (RSV) Therapeutics Production Share by Manufacturers in 2018
Table Respiratory Syncytial Virus (RSV) Therapeutics Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Respiratory Syncytial Virus (RSV) Therapeutics Revenue Market Share of Major Manufacturers (2014-2019)
Figure Respiratory Syncytial Virus (RSV) Therapeutics Revenue Share by Manufacturers in 2018
Table Respiratory Syncytial Virus (RSV) Therapeutics Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Respiratory Syncytial Virus (RSV) Therapeutics Production by Regions 2014-2019 (K Units)
Table Global Respiratory Syncytial Virus (RSV) Therapeutics Production Market Share by Regions 2014-2019
Figure Global Respiratory Syncytial Virus (RSV) Therapeutics Production Market Share by Regions in 2018
Table Global Respiratory Syncytial Virus (RSV) Therapeutics Revenue by Regions 2014-2019 (Million USD)
Table Global Respiratory Syncytial Virus (RSV) Therapeutics Revenue Market Share by Regions 2014-2019
Figure Global Respiratory Syncytial Virus (RSV) Therapeutics Revenue Market Share by Regions in 2018
Table Global Respiratory Syncytial Virus (RSV) Therapeutics Consumption by Regions 2014-2019 (K Units)
Table Global Respiratory Syncytial Virus (RSV) Therapeutics Consumption Market Share by Regions 2014-2019
Figure North America Respiratory Syncytial Virus (RSV) Therapeutics Production Growth Rate 2014-2019 (K Units)
Figure North America Respiratory Syncytial Virus (RSV) Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table North America Respiratory Syncytial Virus (RSV) Therapeutics Production, Consumption Import and Export (K Units)
Figure Europe Respiratory Syncytial Virus (RSV) Therapeutics Production Growth Rate 2014-2019 (K Units)
Figure Europe Respiratory Syncytial Virus (RSV) Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Respiratory Syncytial Virus (RSV) Therapeutics Production, Consumption Import and Export (K Units)
Figure China Respiratory Syncytial Virus (RSV) Therapeutics Production Growth Rate 2014-2019 (K Units)
Figure China Respiratory Syncytial Virus (RSV) Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table China Respiratory Syncytial Virus (RSV) Therapeutics Production, Consumption Import and Export (K Units)
Figure Japan Respiratory Syncytial Virus (RSV) Therapeutics Production Growth Rate 2014-2019 (K Units)
Figure Japan Respiratory Syncytial Virus (RSV) Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Respiratory Syncytial Virus (RSV) Therapeutics Production, Consumption Import and Export (K Units)
Figure Southeast Asia Respiratory Syncytial Virus (RSV) Therapeutics Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Respiratory Syncytial Virus (RSV) Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Respiratory Syncytial Virus (RSV) Therapeutics Production, Consumption Import and Export (K Units)
Figure India Respiratory Syncytial Virus (RSV) Therapeutics Production Growth Rate 2014-2019 (K Units)
Figure India Respiratory Syncytial Virus (RSV) Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table India Respiratory Syncytial Virus (RSV) Therapeutics Production, Consumption Import and Export (K Units)
Figure Global Consumption Respiratory Syncytial Virus (RSV) Therapeutics Market Share by Application (2014-2019)
Figure Global Value (Consumption) Respiratory Syncytial Virus (RSV) Therapeutics Market Share by Application (2014-2019)
Table Roche Respiratory Syncytial Virus (RSV) Therapeutics Production Sites and Area Served
Table Roche Respiratory Syncytial Virus (RSV) Therapeutics Product Introduction, Application and Specification
Table Roche Respiratory Syncytial Virus (RSV) Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Roche Respiratory Syncytial Virus (RSV) Therapeutics Production Growth Rate (2014-2019)
Table Roche Respiratory Syncytial Virus (RSV) Therapeutics Production Market Share (2014-2019)
Figure Roche Respiratory Syncytial Virus (RSV) Therapeutics Revenue Market Share (2014-2019)
Table Roche Respiratory Syncytial Virus (RSV) Therapeutics Main Business and Markets Served
Table AstraZeneca Respiratory Syncytial Virus (RSV) Therapeutics Production Sites and Area Served
Table AstraZeneca Respiratory Syncytial Virus (RSV) Therapeutics Product Introduction, Application and Specification
Table AstraZeneca Respiratory Syncytial Virus (RSV) Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table AstraZeneca Respiratory Syncytial Virus (RSV) Therapeutics Production Growth Rate (2014-2019)
Table AstraZeneca Respiratory Syncytial Virus (RSV) Therapeutics Production Market Share (2014-2019)
Figure AstraZeneca Respiratory Syncytial Virus (RSV) Therapeutics Revenue Market Share (2014-2019)
Table AstraZeneca Respiratory Syncytial Virus (RSV) Therapeutics Main Business and Markets Served
Table Merck Respiratory Syncytial Virus (RSV) Therapeutics Production Sites and Area Served
Table Merck Respiratory Syncytial Virus (RSV) Therapeutics Product Introduction, Application and Specification
Table Merck Respiratory Syncytial Virus (RSV) Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Respiratory Syncytial Virus (RSV) Therapeutics Production Growth Rate (2014-2019)
Table Merck Respiratory Syncytial Virus (RSV) Therapeutics Production Market Share (2014-2019)
Figure Merck Respiratory Syncytial Virus (RSV) Therapeutics Revenue Market Share (2014-2019)
Table Merck Respiratory Syncytial Virus (RSV) Therapeutics Main Business and Markets Served
Table AbbVie Respiratory Syncytial Virus (RSV) Therapeutics Production Sites and Area Served
Table AbbVie Respiratory Syncytial Virus (RSV) Therapeutics Product Introduction, Application and Specification
Table AbbVie Respiratory Syncytial Virus (RSV) Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table AbbVie Respiratory Syncytial Virus (RSV) Therapeutics Production Growth Rate (2014-2019)
Table AbbVie Respiratory Syncytial Virus (RSV) Therapeutics Production Market Share (2014-2019)
Figure AbbVie Respiratory Syncytial Virus (RSV) Therapeutics Revenue Market Share (2014-2019)
Table AbbVie Respiratory Syncytial Virus (RSV) Therapeutics Main Business and Markets Served
Table Valeant Pharmaceuticals Respiratory Syncytial Virus (RSV) Therapeutics Production Sites and Area Served
Table Valeant Pharmaceuticals Respiratory Syncytial Virus (RSV) Therapeutics Product Introduction, Application and Specification
Table Valeant Pharmaceuticals Respiratory Syncytial Virus (RSV) Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Valeant Pharmaceuticals Respiratory Syncytial Virus (RSV) Therapeutics Production Growth Rate (2014-2019)
Table Valeant Pharmaceuticals Respiratory Syncytial Virus (RSV) Therapeutics Production Market Share (2014-2019)
Figure Valeant Pharmaceuticals Respiratory Syncytial Virus (RSV) Therapeutics Revenue Market Share (2014-2019)
Table Valeant Pharmaceuticals Respiratory Syncytial Virus (RSV) Therapeutics Main Business and Markets Served
Table GlaxoSmithKline Respiratory Syncytial Virus (RSV) Therapeutics Production Sites and Area Served
Table GlaxoSmithKline Respiratory Syncytial Virus (RSV) Therapeutics Product Introduction, Application and Specification
Table GlaxoSmithKline Respiratory Syncytial Virus (RSV) Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table GlaxoSmithKline Respiratory Syncytial Virus (RSV) Therapeutics Production Growth Rate (2014-2019)
Table GlaxoSmithKline Respiratory Syncytial Virus (RSV) Therapeutics Production Market Share (2014-2019)
Figure GlaxoSmithKline Respiratory Syncytial Virus (RSV) Therapeutics Revenue Market Share (2014-2019)
Table GlaxoSmithKline Respiratory Syncytial Virus (RSV) Therapeutics Main Business and Markets Served
Table ReViral Respiratory Syncytial Virus (RSV) Therapeutics Production Sites and Area Served
Table ReViral Respiratory Syncytial Virus (RSV) Therapeutics Product Introduction, Application and Specification
Table ReViral Respiratory Syncytial Virus (RSV) Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table ReViral Respiratory Syncytial Virus (RSV) Therapeutics Production Growth Rate (2014-2019)
Table ReViral Respiratory Syncytial Virus (RSV) Therapeutics Production Market Share (2014-2019)
Figure ReViral Respiratory Syncytial Virus (RSV) Therapeutics Revenue Market Share (2014-2019)
Table ReViral Respiratory Syncytial Virus (RSV) Therapeutics Main Business and Markets Served
Table Gilead Sciences Respiratory Syncytial Virus (RSV) Therapeutics Production Sites and Area Served
Table Gilead Sciences Respiratory Syncytial Virus (RSV) Therapeutics Product Introduction, Application and Specification
Table Gilead Sciences Respiratory Syncytial Virus (RSV) Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Gilead Sciences Respiratory Syncytial Virus (RSV) Therapeutics Production Growth Rate (2014-2019)
Table Gilead Sciences Respiratory Syncytial Virus (RSV) Therapeutics Production Market Share (2014-2019)
Figure Gilead Sciences Respiratory Syncytial Virus (RSV) Therapeutics Revenue Market Share (2014-2019)
Table Gilead Sciences Respiratory Syncytial Virus (RSV) Therapeutics Main Business and Markets Served
Table Teva Pharmaceutical Respiratory Syncytial Virus (RSV) Therapeutics Production Sites and Area Served
Table Teva Pharmaceutical Respiratory Syncytial Virus (RSV) Therapeutics Product Introduction, Application and Specification
Table Teva Pharmaceutical Respiratory Syncytial Virus (RSV) Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Teva Pharmaceutical Respiratory Syncytial Virus (RSV) Therapeutics Production Growth Rate (2014-2019)
Table Teva Pharmaceutical Respiratory Syncytial Virus (RSV) Therapeutics Production Market Share (2014-2019)
Figure Teva Pharmaceutical Respiratory Syncytial Virus (RSV) Therapeutics Revenue Market Share (2014-2019)
Table Teva Pharmaceutical Respiratory Syncytial Virus (RSV) Therapeutics Main Business and Markets Served
Figure Global Respiratory Syncytial Virus (RSV) Therapeutics Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Respiratory Syncytial Virus (RSV) Therapeutics Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Respiratory Syncytial Virus (RSV) Therapeutics Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Respiratory Syncytial Virus (RSV) Therapeutics Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Respiratory Syncytial Virus (RSV) Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Respiratory Syncytial Virus (RSV) Therapeutics Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Respiratory Syncytial Virus (RSV) Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Respiratory Syncytial Virus (RSV) Therapeutics Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Respiratory Syncytial Virus (RSV) Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Respiratory Syncytial Virus (RSV) Therapeutics Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Respiratory Syncytial Virus (RSV) Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Respiratory Syncytial Virus (RSV) Therapeutics Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Respiratory Syncytial Virus (RSV) Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Respiratory Syncytial Virus (RSV) Therapeutics Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Respiratory Syncytial Virus (RSV) Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Respiratory Syncytial Virus (RSV) Therapeutics by Type (2019-2025)
Table Global Consumption (K Units) of Respiratory Syncytial Virus (RSV) Therapeutics by Application (2019-2025)
Table Respiratory Syncytial Virus (RSV) Therapeutics Distributors List
Table Respiratory Syncytial Virus (RSV) Therapeutics Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Roche、AstraZeneca、Merck、AbbVie、Valeant Pharmaceuticals、GlaxoSmithKline、ReViral、Gilead Sciences、Teva Pharmaceutical、

★調査レポート[世界の呼吸器合胞体ウイルス（RSV）治療薬市場 2019年] (コード：DATA909X14332)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の呼吸器合胞体ウイルス（RSV）治療薬市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の急性呼吸窮迫症候群(ARDS)治療薬市場 2019年
    DATA909X02949 / QYResearch / 2019年11月15日 / ※本調査レポートは、急性呼吸窮迫症候群(ARDS)治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、メチルプレドニゾロン、ヒドロコルチゾン、注射用子牛肺サーファクタント、その他に、用途別には、入院患者、外来患者にセグメント区分し、急性呼吸窮迫症候群(ARDS)治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・急性呼吸窮迫症候群(ARDS)治療薬の世界市場概要 ・急性呼吸窮迫症候群(ARDS)治療薬の製造コスト構成分析 ・急性呼吸窮迫症候群(ARDS)治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・急性呼吸窮迫症候群(ARDS)治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・急性呼吸窮迫症候群(ARDS)治療薬のセグメント分析（種類別） （メチルプレドニゾロン、ヒドロコルチゾン、注射用子牛肺サーファクタント、その他）...The global Acute Respiratory Distress Syndrome Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Acute Respiratory Distress Syndrome Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Acute Respiratory Distress Syndrome Therapeutics market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Acute Respiratory Distress Syndrome Therapeutics in North America, Europe, China, Japan, Southeast Asia and...
  • 世界の骨髄異形成症候群（MDS）治療薬市場 2019年
    DATA909X11785 / QYResearch / 2019年11月20日 / ※本調査レポートは、骨髄異形成症候群（MDS）治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アザシチジン、レナリドマイド、デシタビン、デフェラシロクス、その他に、用途別には、入院患者、外来患者にセグメント区分し、骨髄異形成症候群（MDS）治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・骨髄異形成症候群（MDS）治療薬の世界市場概要 ・骨髄異形成症候群（MDS）治療薬の製造コスト構成分析 ・骨髄異形成症候群（MDS）治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・骨髄異形成症候群（MDS）治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・骨髄異形成症候群（MDS）治療薬のセグメント分析（種類別） （アザシチジン、レナリドマイド、デシタビン、デフェラシロクス、その他）...The global Myelodysplastic Syndrome (MDS) Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Myelodysplastic Syndrome (MDS) Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Myelodysplastic Syndrome (MDS) Therapeutics market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Myelodysplastic Syndrome (MDS) Therapeutics in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界の急性心不全(AHF)治療薬市場 2019年
    DATA909X02947 / QYResearch / 2019年11月15日 / ※本調査レポートは、急性心不全(AHF)治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、β遮断薬、カルシウム拮抗薬、強心配糖体、利尿薬、モルヒネ、血管拡張薬/硝酸塩、その他に、用途別には、病院、クリニック、ホームケアにセグメント区分し、急性心不全(AHF)治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・急性心不全(AHF)治療薬の世界市場概要 ・急性心不全(AHF)治療薬の製造コスト構成分析 ・急性心不全(AHF)治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・急性心不全(AHF)治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・急性心不全(AHF)治療薬のセグメント分析（種類別） （β遮断薬、カルシウム拮抗薬、強心配糖体、利尿薬、モルヒネ、血管拡張薬/硝酸塩、その他）...The global Acute Heart Failure (AHF) Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Acute Heart Failure (AHF) Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Acute Heart Failure (AHF) Therapeutics market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Acute Heart Failure (AHF) Therapeutics in North America, Europe, China, Japan, Southeast Asia and...
  • 世界の多発性硬化症（MS）治療薬市場 2019年
    DATA909X11757 / QYResearch / 2019年11月20日 / ※本調査レポートは、多発性硬化症（MS）治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、コパキソン（酢酸グラチラマー、共重合体1）、ノバントロン（ミトキサントロン）、ギレニア（フィンゴリモド、Fty720）、オーバジオ（テリフルノミド）、テクフィデラ（フマル酸ジメチル）、フィラテグラス（Sb683699、T-0047）、シポニモド（Baf312）、その他に、用途別には、RRMS、SPMS、PPMS、PRMSにセグメント区分し、多発性硬化症（MS）治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・多発性硬化症（MS）治療薬の世界市場概要 ・多発性硬化症（MS）治療薬の製造コスト構成分析 ・多発性硬化症（MS）治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・多発性硬化症（MS）治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・多発性硬化症（MS）治療薬のセグメント分析（種類別） （コパキソン（酢酸グラチラマー、共重合体1）、ノバントロン（ミトキサントロン）、ギレニア（フィンゴリモド、Fty720）、オーバジオ（テリフルノミド）、テクフィデラ（フマル酸ジメチル）、フィラテグラス（Sb683699、T-0047）、シポニモド（Baf312）、その他）...The global Multiple Sclerosis (MS) Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Multiple Sclerosis (MS) Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Multiple Sclerosis (MS) Drugs market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Multiple Sclerosis (MS) Drugs in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界の肺動脈高血圧症（PAH）治療薬市場 2019年
    DATA909X13888 / QYResearch / 2019年11月20日 / ※本調査レポートは、肺動脈高血圧症（PAH）治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、エンドセリン受容体拮抗薬（ERA）、プロスタサイクリンおよびプロスタサイクリンアナログ、ホスホジエステラーゼ5（PDE-5）、可溶性グアニル酸シクラーゼ（SGC）刺激剤に、用途別には、二次性肺高血圧症（SPH）、原発性肺高血圧症（PPH）にセグメント区分し、肺動脈高血圧症（PAH）治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・肺動脈高血圧症（PAH）治療薬の世界市場概要 ・肺動脈高血圧症（PAH）治療薬の製造コスト構成分析 ・肺動脈高血圧症（PAH）治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・肺動脈高血圧症（PAH）治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・肺動脈高血圧症（PAH）治療薬のセグメント分析（種類別） （エンドセリン受容体拮抗薬（ERA）、プロスタサイクリンおよびプロスタサイクリンアナログ、ホスホジエステラーゼ5（PDE-5）、可溶性グアニル酸シクラーゼ（SGC）刺激剤）...The global Pulmonary Arterial Hypertension (PAH) Medicine market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Pulmonary Arterial Hypertension (PAH) Medicine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Pulmonary Arterial Hypertension (PAH) Medicine market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Pulmonary Arterial Hypertension (PAH) Medicine in North America, Europe, China, Japan, Southeast Asia and...
  • 世界の多嚢胞性卵巣症候群（PCOS）治療薬市場 2019年
    DATA909X13285 / QYResearch / 2019年11月20日 / ※本調査レポートは、多嚢胞性卵巣症候群（PCOS）治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、経口避妊薬、抗炎症薬、インスリン抵抗性改善薬、抗高血圧薬、抗肥満薬に、用途別には、病院、クリニックにセグメント区分し、多嚢胞性卵巣症候群（PCOS）治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・多嚢胞性卵巣症候群（PCOS）治療薬の世界市場概要 ・多嚢胞性卵巣症候群（PCOS）治療薬の製造コスト構成分析 ・多嚢胞性卵巣症候群（PCOS）治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・多嚢胞性卵巣症候群（PCOS）治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・多嚢胞性卵巣症候群（PCOS）治療薬のセグメント分析（種類別） （経口避妊薬、抗炎症薬、インスリン抵抗性改善薬、抗高血圧薬、抗肥満薬）...The global Polycystic Ovary Syndrome (PCOS) Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Polycystic Ovary Syndrome (PCOS) Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Polycystic Ovary Syndrome (PCOS) Drugs market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Polycystic Ovary Syndrome (PCOS) Drugs in North America, Europe, China, Japan, Southeast Asia and...

    • ◆H&Iグローバルリサーチのお客様（例）◆